Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Over the last 12 months, insiders at Zynex, Inc. have bought $58,233 and sold $854,590 worth of Zynex, Inc. stock.
On average, over the past 5 years, insiders at Zynex, Inc. have bought $53,864 and sold $14.04M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Disbrow Joshua R. (director) — $116,466.
The last purchase of 7,000 shares for transaction amount of $58,233 was made by Disbrow Joshua R. (director) on 2024‑07‑29.
2025-02-03 | Sale | CHIEF FINANCIAL OFFICER | 10,000 0.0308% | $7.68 | $76,800 | +3.43% | ||
2025-01-02 | Sale | CHIEF FINANCIAL OFFICER | 10,000 0.0316% | $7.88 | $78,800 | +2.94% | ||
2024-12-02 | Sale | CHIEF FINANCIAL OFFICER | 10,000 0.0308% | $8.08 | $80,800 | -1.46% | ||
2024-11-14 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0064% | $8.09 | $16,180 | 0.00% | ||
2024-11-13 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0065% | $8.37 | $16,740 | 0.00% | ||
2024-11-12 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0068% | $9.24 | $18,480 | -5.13% | ||
2024-11-11 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0062% | $9.09 | $18,180 | -12.58% | ||
2024-11-08 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0061% | $8.77 | $17,540 | -9.77% | ||
2024-11-07 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0065% | $9.17 | $18,340 | -7.87% | ||
2024-11-06 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0061% | $8.82 | $17,640 | -11.62% | ||
2024-11-05 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0063% | $8.05 | $16,100 | 0.00% | ||
2024-11-04 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0068% | $8.67 | $17,340 | +1.75% | ||
2024-11-01 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0062% | $8.63 | $17,260 | -7.08% | ||
2024-11-01 | Sale | CHIEF FINANCIAL OFFICER | 10,000 0.0308% | $8.59 | $85,900 | -7.08% | ||
2024-10-31 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0064% | $8.82 | $17,640 | -5.68% | ||
2024-10-30 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0062% | $8.92 | $17,840 | -9.76% | ||
2024-08-07 | Sale | CHIEF OPERATING OFFICER | 8,083 0.0255% | $8.03 | $64,906 | +0.12% | ||
2024-08-06 | Sale | CHIEF OPERATING OFFICER | 16,792 0.0532% | $8.01 | $134,504 | +0.82% | ||
2024-07-30 | Sale | CHIEF FINANCIAL OFFICER | 15,000 0.0474% | $8.24 | $123,600 | +1.33% | ||
2024-07-29 | director | 7,000 0.022% | $8.32 | $58,233 | -3.66% |
Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN | 14603662 45.8579% | $7.66 | 21 | 50 | |
Disbrow Joshua R. | director | 72000 0.2261% | $7.66 | 1 | 0 | |
MOORHEAD DANIEL J | CHIEF FINANCIAL OFFICER | 19738 0.062% | $7.66 | 2 | 16 | +30.13% |
Lucsok Anna | CHIEF OPERATING OFFICER | 16980 0.0533% | $7.66 | 0 | 4 |
Increased Positions | 39 | +27.86% | 559,710 | +5.7% |
Decreased Positions | 58 | -41.43% | 2M | -19.13% |
New Positions | 10 | New | 85,930 | New |
Sold Out Positions | 24 | Sold Out | 369,244 | Sold Out |
Total Postitions | 121 | -13.57% | 9M | -13.43% |
Vanguard Group Inc | $9,236.00 | 3.68% | 1.18M | +9,629 | +0.82% | 2024-09-30 |
Blackrock, Inc. | $9,187.00 | 3.66% | 1.17M | -71,318 | -5.74% | 2024-09-30 |
Hotchkis & Wiley Capital Management Llc | $5,852.00 | 2.33% | 746,380 | +147,770 | +24.69% | 2024-09-30 |
Nantahala Capital Management, Llc | $3,842.00 | 1.53% | 490,000 | -490,000 | -50% | 2024-09-30 |
Geode Capital Management, Llc | $3,336.00 | 1.33% | 425,509 | +26,774 | +6.71% | 2024-09-30 |
State Street Corp | $2,964.00 | 1.18% | 378,030 | -9,172 | -2.37% | 2024-09-30 |
Bridge City Capital, Llc | $2,315.00 | 0.92% | 295,289 | +102,000 | +52.77% | 2024-09-30 |
Arrowstreet Capital, Limited Partnership | $2,024.00 | 0.81% | 258,193 | -56,160 | -17.86% | 2024-09-30 |
Royce & Associates Lp | $2,017.00 | 0.8% | 257,291 | +21,781 | +9.25% | 2024-09-30 |
Rice Hall James & Associates, Llc | $1,794.00 | 0.72% | 228,786 | -1,892 | -0.82% | 2024-12-31 |